FGF21 and metabolic dysfunction-associated steatotic liver disease: In clinical terms, higher FGF-21 levels were shown in patients with NAFLD than in individuals without NAFLD in most, but not all studies; similarly, data on circulating FGF-21 levels between patients with simple hepatic steatosis and steatohepatitis are inconclusive.